Q1 2022 · 13F-HR
Atlas Venture Associates IX, LLCholdings as filed
Filed 2022-05-12 · accession 0001104659-22-059330
$108,732
Reported value
7
Positions
2022-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 83067L109 | — | SKILLZ INC | $68,730 | 63.2% | 22,909,859 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $11,980 | 11.0% | 1,376,968 | Common | SOLE |
| 86877M209 | — | SURFACE ONCOLOGY INC | $8,660 | 7.96% | 2,945,453 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $6,867 | 6.32% | 916,832 | Common | SOLE |
| 87166L100 | — | SYNLOGIC INC | $6,364 | 5.85% | 2,651,963 | Common | SOLE |
| 83304A106 | SNAP | SNAP INC | $5,404 | 4.97% | 150,160 | Common | NONE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $727 | 0.67% | 10,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.